# Pier Luigi Zinzani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/pier-luigi-zinzani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 62,630 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 118 |
| i10-index | 651 |
| Last Known Institution | IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola |
| OpenAlex ID | https://openalex.org/A5091882595 |
| ORCID iD | https://orcid.org/0000-0002-2112-2651 |
| Works | 1,848 |

## Researcher papers

- [Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial](https://scholariq.org/papers/addition-of-rituximab-to-fludarabine-and-cyclophosphamide-in-patients-with/)
- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)
- [Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial](https://scholariq.org/papers/mogamulizumab-versus-vorinostat-in-previously-treated-cutaneous-t-cell-lymphoma/)
- [International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease](https://scholariq.org/papers/international-evidence-based-consensus-treatment-guidelines-for-idiopathic/)
- [Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations](https://scholariq.org/papers/immune-effector-cell-associated-hematotoxicity-eha-ebmt-consensus-grading-and/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)

## Researcher university

- [IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola](https://scholariq.org/institutions/irccs-azienda-ospedliero-universitaria-di-bologna-policlinico-di-sant-orsola/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.